The role of α- and β-adrenoceptor blockade in antihypertensive treatment P. A. van Zwieten Pathophysiology Pages: S7 - S12
Oral administration of carvedilol and prazosin inhibits the prostaglandin F2α- and noradrenaline-induced contraction of human hand veins in vivo C. BeermannJ. SchloosG. G. Belz Pathophysiology Pages: S13 - S19
Pharmacological profile of β-adrenoceptor blockers with vasodilating properties, especially carvedilol — rationale for clinical use G. SponerW. BartschK. Strem Clinical Pharmacology Pages: S20 - S26
Clinical pharmacology of carvedilol B. TomlinsonB. N. C. PrichardR. J. Walden Clinical Pharmacology Pages: S27 - S36
Antihypertensive effect of carvedilol: a preliminary dose-response study B. CasadeiJ. ConwayR. Bird Clinical Pharmacology Pages: S37 - S38
Clinical experience with dual-acting drugs in hypertension K. H. Rahn Clinical Pharmacology Pages: S39 - S42
Antihypertensive profile of carvedilol W. Meyer-SabellekB. Agrawal Antihypertensive Therapy Pages: S43 - S52
Comparison of the antihypertensive effects of carvedilol and metoprolol on resting and exercise blood pressure I. -W. FranzB. AgrawalR. Ketelhut Antihypertensive Therapy Pages: S53 - S57
Long-term hemodynamic effects of antihypertensive treatment P. Lund-JohansenP. OmvikJ. E. Nordrehaug Antihypertensive Therapy Pages: S58 - S64
Hemodynamic and metabolic effects of carvedilol: a meta-analysis approach U. StienenW. Meyer-Sabellek Antihypertensive Therapy Pages: S65 - S72
Pathophysiology and triggers of acute myocardial infarction: clinical implications S. N. WillichA. H. JimenezJ. E. Muller Carvedilol and The Heart Pages: S73 - S78
Left ventricular hypertrophy regression during antihypertensive treatment H. EichstaedtO. DanneD. Kreuz Carvedilol and The Heart Pages: S79 - S86
Therapeutic effect on left ventricular hypertrophy by different antihypertensive drugs W. MotzB. E. Strauer Carvedilol and The Heart Pages: S87 - S92
Acute hemodynamic effects of carvedilol in comparison with propranolol in patients with coronary heart disease T. Wendt Carvedilol and The Heart Pages: S93 - S97
Can intravenous beta blockade predict long-term haemodynamic benefit in chronic congestive heart failure secondary to ischaemic heart disease? A comparison between intravenous and oral carvedilol P. DasGuptaA. Lahiri Carvedilol and The Heart Pages: S98 - S104
Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes M. R. BristowP. LarrabeeJ. D. Port Carvedilol and The Heart Pages: S105 - S113
Clinical relevance of albuminuria in hypertensive patients E. RitzD. Fliser Carvedilol and The Kidney Pages: S114 - S119
Influence of antihypertensive therapy on renal function U. FreiR. SchindlerK. M. Koch Carvedilol and The Kidney Pages: S120 - S126